The Helmholtz Institute for RNA-based Infection Research (HIRI) is the first institution of its kind worldwide to combine ribonucleic acid (RNA) research with infection biology. Based on novel findings from our strong basic research program, our long-term goal is to develop innovative therapeutic approaches to better diagnose and treat human infections. HIRI is a site of the Braunschweig Helmholtz Centre for Infection Research (HZI) in cooperation with the Julius-Maximilians-Universität Würzburg (JMU) and is located on the Würzburg Medical Campus. #RNAexcellence
Externer Link zu Helmholtz Institute Würzburg (HIRI)
Josef-Schneider-Straße 2
Würzburg, Bavaria 97080, DE
For those of you who missed the RNA Collaborative Seminar, we have good news! 🧬📺 You can now watch it here: https://lnkd.in/gEYCR9fY
Attention, #RNA Community! 🧬 Join us today at 4 PM CET for the #HIRI-hosted RNA Collaborative Seminar, featuring talks by HIRI director Jörg Vogel & Daniel Ryan, Ph.D, postdoc in the Westermann lab. Neva Caliskan will moderate the session. More at:
🚨 JOB ALERT 🚨 The Helmholtz Institute Würzburg is currently #HIRIng a #ScientificCoordinator. If you're looking for an exciting position at the interface of science and management, this opportunity is for you. 🫵 Apply by August 4 at
Ausgetrickste Bakterien 🃏🦠 Schöner Artikel im Laborjournal über die jüngste Publikation aus #HIRI's Beisel-Labor. Reinlesen lohnt sich! https://lnkd.in/e8tXR5N2
Helmholtz Institute Würzburg (HIRI) hat dies direkt geteilt
On October 8, the first #HelmholtzHealthSummit will take place in Berlin! HZI researcher Dr. Milan Gerovac will be a speaker: He is developing medically relevant tools based on #bacteriophages. Further information on the event and registration: https://lnkd.in/eY-br7cb Helmholtz-Gemeinschaft Helmholtz Munich DKFZ Deutsches Krebsforschungszentrum Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) Helmholtz-Zentrum Dresden-Rossendorf (HZDR) Max Delbrück Center Helmholtz Institute Würzburg (HIRI) #Health #Innovation #HelmholtzHealthHero #Helmholtz #MedicalInnovation #HealthcareFuture #HealthTech #PrecisionMedicine #AIinHealthcare #FutureHealth #DigitalHealth #HealthResearch #Prevention #BiomedicalEngeneering #Transfer #Spinoffs #Translation
Helmholtz Institute Würzburg (HIRI) hat dies direkt geteilt
In order to exploit the full potential of bacteria, it is necessary to genetically modify them. Chase Beisel from the HZI site Helmholtz Institute Würzburg (HIRI) is now presenting the method IMPRINT. The cell-free system simplifies the DNA transformation of various bacterial strains. https://lnkd.in/eJ5istiv
Laboratories provide controlled environments for experiments and measurements, fostering numerous inventions and discoveries. ⚗🔬 At the #HIRI, lab and infrastructure manager Christiane Albert-Weißenberger ensures that research in the lab runs smoothly. In this interview, she talks about her work and responsibilities, the most exciting spot in the lab, and what the laboratories of the future might look like: https://lnkd.in/eADaxmRE
Attention, #RNA Community! 🧬 Join us today at 4 PM CET for the #HIRI-hosted RNA Collaborative Seminar, featuring talks by HIRI director Jörg Vogel & Daniel Ryan, Ph.D, postdoc in the Westermann lab. Neva Caliskan will moderate the session. More at:
Helmholtz Institute Würzburg (HIRI) hat dies direkt geteilt
New technology alert! Introducing IMPRINT, a cell-free method for rapidly methylating DNA to increase its transformation into bacteria. https://lnkd.in/dNFpDxnj The vast world of bacteria holds great potential to develop novel products in diverse fields, from sustainable chemical factories to living therapeutics that combat disease and promote well-being in humans as well as in agricultural crops. However, studying and engineering bacteria is largely hindered by an inability to deliver DNA into their cells, often due to the presence of bacterial defense systems that eliminate foreign DNA. As a result, current efforts mostly rely on the few "model" bacteria such as E. coli that can be engineered -- but what if we can tap into the multitude of other bacteria that possess unique and often superior traits specific to their environment? Using IMPRINT, we show increased DNA transformation in relevant pathogenic (Salmonella) and probiotic (Bifidobacteria) strains of bacteria, develop a method to quickly decipher the "optimal" methylation pattern on transformed DNA for a particular strain, and illustrate how the boost in transformation facilitates the use of high-throughput screens in "non-model" bacteria. It's been super fun and rewarding to lead this project and see it develop over the years into something useful, and it took a full team effort! Huge shoutout to everyone involved Chase Beisel Nathan Crook Deniz Durmusoglu Tianyu Li John van Schaik Sean Sullivan Fani Ttofali Lars Barquist Costas Patinios Yanying Yu and Yanyan Wang!
A truly well-crafted portrait of our #HIRI group leader, Mathias Munschauer! 👏 Check it out if you haven't already. ⬇
A daring e-mail took biochemist Mathias Munschauer from Mannheim to New York, to the laboratory of one of the world’s most renowned #RNA researchers. Today, he is one of the most sought-after experts in the field. Read his portrait on our website: https://lnkd.in/eb2dWiqY Helmholtz Institute Würzburg (HIRI) #RNAexcellence
Hip, hip, hooray! 🎉🎓 On June 10, Gianluca Prezza from #HIRI’s Westermann lab successfully defended his doctoral dissertation. Congratulations, Gianluca! The HIRI family is celebrating with you. Read more: https://lnkd.in/eV_gXUwS